Figure 1From: CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantationPercentage of peripheral blood CD14+CD16+ monocytes after kidney allograft transplantation. The co-expression of CD14 and CD16 antigens on peripheral blood monocytes was evaluated by flow cytometry in three different groups of patients undergoing kidney allograft transplantation (a-without induction, b-thymoglobulin, c-basiliximab). In patients without the induction therapy (n = 25 ) and those treated with thymoglobulin (n = 28 ), the percentage of CD14+CD16+ monocytes decreased during the first two weeks after the transplantation as compared to only moderate changes observed in subjects treated with basiliximab (n = 18). Analysis of data from flow cytometry was performed by ANOVA with repeated measures and a comparison within groups between two time points by contrasts. *Statistically significant differences.Back to article page